Roundup and non-Hodgkin lymphoma claims

Roundup claims allege that exposure to glyphosate-based herbicide caused non-Hodgkin lymphoma. The strongest claims involve sustained occupational or heavy residential exposure — groundskeepers, farm and nursery workers, landscapers — rather than occasional garden use.

Reviewed by Omar A. Cooper, Esq. · Last updated September 3, 2026

What the litigation is about

In 2015 the International Agency for Research on Cancer classified glyphosate as probably carcinogenic to humans, a finding that other regulators have assessed differently. That disagreement is genuinely part of the litigation and any honest page has to say so.

What the claims allege is not merely that the product is dangerous but that the manufacturer knew enough to warn users, and did not.

Who may qualify

Eligibility in this litigation generally turns on:

• meaningful exposure to a glyphosate-based herbicide — occupational exposure is the strongest;
• a diagnosis of non-Hodgkin lymphoma or a recognised subtype;
• the interval between exposure and diagnosis;
• the applicable filing deadline in your state.

What we will ask you for

A review moves quickly when you have these to hand — and none of them are required to call:

• the pathology report identifying the lymphoma subtype;
• employment records establishing the role and the years;
• purchase records for heavy residential users;
• any applicator licensing or training records;
• photographs of the product used, where they exist.

No outcome can be promised in any mass tort, and eligibility is not the same as recovery. What an eligibility review gives you is a straight answer about whether a claim exists and whether it is worth pursuing.

Sources: IARC Monograph 112 — glyphosate · U.S. Judicial Panel on Multidistrict Litigation — pending MDL statistics

Common questions